6. Hing KA: Bone repair in the twenty-first century: biology, chemistry or engineering? Philos. Trans. A Math. Phys. Eng Sci. 2004; 362: 2821–2850

7. Le Guéhennec L, Layrolle P, and Daculsi G. A review of bioceramics and fibrin sealant. Eur. Cell Mater. 2004; 8: 1–10

8. Damron TA: Use of 3D beta-tricalcium phosphate (Vitoss) scaffolds in repairing bone defects. Nanomedicine 2007; 2: 763–775

9. Khan Y, Yaszemski MJ, Mikos AG et al. Tissue engineering of bone: material and matrix considerations. J. Bone Joint Surg. Am. 2008; 90 Suppl 1: 36–42

10. Wahl DA and Czernuszka JT. Collagen-hydroxyapatite composites for hard tissue repair. Eur. Cell Mater. 2006; 11: 43–56

11. Wippermann, BW. Hydroxylapatitkeramik als Knochenersatzwerkstoff. Berlin: Springer; 1997

12. Knabe C, Ducheyne P: Cellular response to bioactive ceramics. In Bioceramics and their clinical applications, Cambridge: Woodhead Publishing Limited, 2008: 133–164

13. Peters F, Reif D: Functional materials for bone regeneration from beta-tricalcium phosphate. Mat.-wiss.u.Werkstofftech. 2004; 35: 203–207

14. Horowitz RA, Mazor Z, Miller RJ et al.: Clinical evaluation alveolar ridge preservation with a beta-tricalcium phosphate socket graft. Compend. Contin. Educ. Dent. 2009; 30: 588–90, 592, 594

15. Horch HH, Sader R, Pautke C: Synthetic, pure-phase beta-tricalcium phosphate ceramic granules (Cerasorb) for bone regeneration in the reconstructive surgery of the jaws. Int. J. Oral Maxillofac. Surg. 2006; 35: 708–713

16. Szabo G, Huys L, Coulthard P et al.: A prospective multicenter randomized clinical trial of autogenous bone versus beta-tricalcium phosphate graft alone for bilateral sinus elevation: histologic and histomorphometric evaluation. Int. J. Oral Maxillofac. Implants. 2005; 20: 371–381

17. Zijderveld SA, Zerbo IR, van den Bergh JP et al. Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts. Int. J. Oral Maxillofac. Implants. 2005; 20: 432–440

18. Harel N, Moses O, Palti A et al.: Long-term results of implants immediately placed into extraction sockets grafted with beta-tricalcium phosphate: a retrospective study. J. Oral Maxillofac. Surg. 2013; 71: e63–e68

19. Gruber AA: Practical applications of a bone substitute – Beta-tricalcium phosphate in hand surgery. Trauma Linc 1999; 2: 50–58

20. Jerosch J, Bader A, Uhr G: Knochen – curasan Taschenatlas spezial. Stuttgart: Thieme; 2002

21. Scheer H, Adolfsson LE: Tricalcium phosphate bone substitute in corrective osteotomy of the distal radius. Injury 2009; 40: 262–267

22. Hinz P, Wolf E, Schwesinger G et al.: A new resorbable bone void filler in trauma: early clinical experience and histologic evaluation. Orthopedics 2002; 25: s597–s600

23. Jakubietz MG, Gruenert JG, Jakubietz RG: The use of beta-tricalcium phosphate bone graft substitute in dorsally plated, comminuted distal radius fractures. J. Orthop. Surg. Res. 2011; 6: 24

24. Maus U, Andereya S, Gravius S et al.: Klinische Erfahrungen mit dem resorbierbaren Knochenersatzstoff Cerasorb. Orthopädische Praxis 2006; 43:, 258–261

25. Gerngross H, Burri C, Kinzl L et al.: Complications at removal sites of autologous cancellous bone transplants. Aktuelle Traumatol. 1982; 12: 146–152

26. Jäger M, Westhoff B, Wild A et al.: Bone harvesting from the iliac crest. Orthopäde 2005; 34: 976–90, 992

27. Mazock JB, Schow SR, Triplett RG: Posterior iliac crest bone harvest: review of technique, complications, and use of an epidural catheter for postoperative pain control. J. Oral Maxillofac. Surg. 2003; 61: 1497–1503

28. Younger EM, Chapman MW: Morbidity at bone graft donor sites. J. Orthop. Trauma 1989; 3: 192–195

29. Ogose A, Hotta T, Kawashima H et al.: Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitutes after excision of bone tumors. J. Biomed. Mater. Res. B Appl. Biomater. 2005; 72: 94–101

30. Van Hoff C, Samora JB, Griesser MJ et al.: Effectiveness of ultraporous beta-tricalcium phosphate (vitoss) as bone graft substitute for cavitary defects in benign and low-grade malignant bone tumors. Am. J. Orthop. 2012; 41: 20–23

Fussnoten

1 RTZ Nürnberg